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Nephrotoxic effects of cadmium exposure are well established in humans and experimental animals. An early manifestation of such toxicity is calci-
uria a few hours after injection of CdMT in rats. Protection against calciuria and other adverse effects such as proteinuria (occurring later) is offered
by pretreatment with Cd, which effectively induces metallothionein synthesis. In the present experiment, one group of animals was given pretreat-
ment with CdCI2 to induce metallothionein synthesis. The comparison group was left without pretreatment. The distribution of Cd from a normally
nephrotoxic dose of 109CdMT was studied by gel chromatography in subcellular fractions of kidney cortex in both groups. In the pretreated animals,
109Cd in the plasma membrane and microsome fractions of renal cortical cells was mainly bound to metallothionein and other low molecular weight
proteins at 4 hr. In nonpretreated animals the major part of 109Cd was bound to high molecular weight proteins. These findings indicate that mem-
brane proteins may be important targets for Cd when inducing nephrotoxicity and that sequestering of Cd by metallothionein (and other low molecu-
lar weight proteins) may be a mechanism of protection. - Environ Health Perspect 102(Suppl 3):191-194 (1994)
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Introduction
Renal tubular dysfunction may develop in
experimental animals and in humans as a
result of long-term exposure to Cd (1).
After absorption via pulmonary or gas-
trointestinal routes, Cd is transported in
plasma initially bound to albumin and
other larger proteins (2). Cadmium-albu-
min is taken up predominantly by the liver
and Cd is released from albumin in this
organ. The released Cd induces synthesis of
metallothionein in liver; and some time
after uptake in the liver, most Cd is bound
to metallothionein (3). A small proportion
of metallothionein-bound Cd will be
released into plasma, and because ofits low
molecular weight, it will be efficiently
transported through the glomerular mem-
brane and will reach the tubular fluid in
the kidney. It will be further taken up by
pinocytotic vesicles in the brush border of
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the proximal tubule and transported into
lysosomes where metallothionein is split
from Cd (4-6). The released Cd is believed
to constitute the toxic principle in cell. The
rate at which such Cd is bound to newly
synthesized metallothionein in renal cells is
believed to be a key factor in determining
whether or not renal tubular damage occurs
(7-9). Pretreatment with CdCl2, which
effectively induces the synthesis of metal-
lothionein in renal cells, prevented acute
nephrotoxicity from normally occurring
after an injected challenge dose (0.4 mg/kg)
of Cd-metallothionein (10). These obser-
vations gave general support to the idea
that intracellular metallothionein can prevent
toxicity by sequestering Cd from sensitive
targets. However, it has not previously
been demonstrated which cellular compo-
nents are the critical targets for Cd in the
renal cells, and it has thus been difficult to
demonstrate the role of metallothionein-
bound and nonmetallothionein-bound Cd
in relation to development ofrenal damage.
In recent studies (11,12), it was shown that
an increased urinary Ca excretion is an
early manifestation ofCd nephrotoxicity in
the Cd-metallothionein injection model
and that such toxicity can be prevented by
pretreatment with CdCl2. The aim of the
present study was to try to identify the sub-
cellular targets of Cd nephrotoxicity by
studying the binding ofCd to various pro-
teins in subcellular fractions from the renal
cortex ofrats. By examining possible differ-
ences in such binding between animals
with or without protective pretreatment,
the importance of various targets for
expression of toxicity could be indicated.
Previously developed models for induction
of nephrotoxicity and protective pretreat-
ment (10,12) were employed.
Materials and Methods
Animals
Male Wistar rats (200-250 g) from ALAB
(Stockholm, Sweden) were used in this
study. All animals were allowed to acclima-
tize for a minimum of 7 days prior to the
experiment; they were maintained under
controlled environmental conditions of
temperature and humidity and with a 12-
hr day-night cycle (2 A.M.-2 P.M.). Tap
water and food (Ewos-ALAB rat-mouse
food R3) were provided ad libitum. Four
groups of rats, each consisting of two ani-
mals, were studied. Groups A and B were
not pretreated with Cd but were subcuta-
neously injected with normal saline. The
rats in groups C and D were given subcuta-
neous pretreatment injections with CdC12
in doses increasing in the following order:
0. 5, 1, 1, 2, 2 mg Cd/kg during 5 consec-
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Figure 1. Preparation of subcellular fractions from rat
kidneycortex.
utive days. A challenge dose of 109CdMT
(0.4 mg Cd/kg, sc) was given to each ani-
mal in all groups 48 hr after the last pre-
treatment injection. All injections were
given at 8 A.M. Animals in groups A and B
were sacrificed by cervical dislocation 1 hr
after, and those in groups Cand D, 4 hrafter
injection of 09CdMT. The kidneys were
immediately excised and used for the
preparation ofsubcellular fractions.
SubcellularFracdonation
The subcellular fractions were prepared
(Figure 1) by a differential centrifugation
method described by Maunsbach (13).
The kidney cortex was dissected into small
pieces and homogenized at 800 rpm and
100 strokes with a glass-Teflon homoge-
nizer in cold 0.25 M sucrose and 0. 01 M
Tris-HCl buffer in 0. 05 M NaCl, pH 7.5.
The homogenate was centrifuged at 10OOg
for 10 min. The pellets were rehomoge-
nized and spun at 1iOOg for another 10
min. The resulting pellet was designated
the nuclear fraction (1OOOg). The super-
natants were combined and spun at 9500g
for 10 min. The pellets were resuspended
and spun at 9500gagain. The resulting pel-
let was used as mitochondria fraction
(9500g). The supernatants and lighter pel-
let portion were combined and spun at
29,700g for 10 min. The pellet obtained
was designated the lysosome fraction
(29,700g). The supernatants were spun at
47,000g for 20 min. This pellet was the
plasma membrane (47,000g4). The super-
natant was centrifuged at 105,000g for 60
min. Centrifugation was performed at 40C.
The pellet was used as microsome fraction
(105,OO0g) and the supernatant as the
cytosol fraction. 109Cd content in the sub-
cellular fractions was determined by
Packard gamma scintillation system
(Packard Instrument Co.) as described by
Nordberg and Nishiyama (14).
Chemicals
Tris-(hydroxymethyl)-aminomethan was
from Merck (Germany). 109Cd was pur-
chased from Amersham (UK). DOC
(Deoxycholic acid sodium salts) was from
Fulka Biochemicka (Switzerland). 109CdMT
was prepared from rat liver as described by
Nordberg et al. (15). The metallothionein
used in the present study had a Cd/Zn
ratio of 37.0/13.5 and a E250/E280 ratio
of3.92.
Preparation ofSubcellular Protein
Complexes
The subcellular fractions were solubilized
with 1% sodium deoxycholate (DOC) by
stirring for 15 min in an ice-cold bath
under a nitrogen stream. Each fraction was
adjusted to contain 1.5% protein. Each sol-
ubilized fraction was applied to a column
packed with Sephadex G-75 (26 x 364
Table 1. Total concentration of "'Cd in renal cortex, and distribution of t'Cd among subcellular fractions in various
groupsa
Group A B C D
Pretreatment+- - - + +
Survival time, hr 1 hr 4 hr 1 hr 4 hr
Total concentration of'0Cd, pg/g wetwt 9.86 23.4 10.4 21.0
Nuclear, % 17 25 9 15
Mitochondria, % 12 7 11 5
Lysosome, % 9 8 10 9
Membrane, % 3 4 2 3
Microsome, % 3 4 3 3
Cytosol, % 56 52 65 65
aPercent oftotal amount in homogenate.
mm). The column was eluted with 0.01 M
Tris-HCl 0.05 M NaCl buffer, pH 7.5,
containing 0.1% DOC and performed at
4°C. A portion of each fraction (3.5 ml)
was assayed for absorbance at 250 nm and
109Cd was estimated by 7-counting. The
recovery of 109Cd was 84 to 102% of the
amount applied to the column.
Results
In the present studies metallothionein syn-
thesis was induced in renal cells by a previ-
ously tested pretreatment schedule with
nonradioactive Cd (10). A challenge dose
of radiolabeled 109CdMT, sufficient to
induce renal damage with proteinuria in
nonpretreated animals (10,11), but not in
pretreated animals, was given subcuta-
neously. The binding of 109Cd in proteins
of subcellular fractions of renal cells was
studied 1 hr and 4 hr after the challenge
dose.
Measured concentrations of Cd in the
renal cortex and the distribution among
subcellular fractions in animals from vari-
ous groups are shown in Table 1. Renal-
cortical Cd concentrations are similar to
those previously reported at 24 hr after
CdMT injection (10) and no obvious dif-
ferences among groups related to pretreat-
ment can be seen in total cortical Cd
concentrations. There is a tendency
towards a displacement of Cd from other
fractions into the cytosol in the pretreated
animals, but the proportions recovered in
"membrane" and "microsome" fractions
are not much different between pretreated
and nonpretreated animals.
The results ofgel filtration ofsubcellu-
lar fractions are shown in Figure 2 and
Table 2. Whereas the distribution of109Cd
was similar at 1 hr after the injection in
nonpretreated and pretreated animals
(groups A and C) there was a clear differ-
ence at 4 hr (groups B and D). In the non-
pretreated animals (group B), most of the
radioactivity appeared in high molecular
weight (HMW) fractions, while, in the
pretreated animals (group D), a major pro-
portion of'09Cd appeared in two low mol-
ecularweight peaks, possiblycorresponding
to metallothionein in monomeric and
dimeric form. This is shown also in Table
2 where the fractional distribution oftotal
l19Cd in the various subcellular fractions is
given. When considering the proportion of
total membrane or microsome 1 Cd that
is found in the HMW-fraction, there is no
important difference between pretreated
and nonpretreated animals at 1 hr, but a
marked difference with 88% ("mem-
brane") and 87% ("microsome") in HMW
Environmental Health Perspectives 192SUBCELLULAR TARGETS OFCADMIUMNEPHROTOXICITY ~~A
40- 0.4-
30- 0.3-
20- 0.2 -
40- 0.4
30- 0.3-
20- 0.2 -
10- 0.1 -
40 - 0.4-
30- 0.3-
20- 0.2- '
10_ 0.1-
/w>__£s_1_o x
40- 0.4-
30- 0.3-
20- 0.2-
10- 0.1-
11 I
I,I
II
-,
" r
1 2
Ve/Vo
B
I ,J
A
,1
'I
1 2
Ve/Vo
C
I,,
%-
I'
I I
I
I I
I
-r
I,
.
\
\' , I,
1 2
Ve/Vo
D
II
II
KII/
\~'I '
*1
II1
I,
I"
1 2
Ve/Vo
Figure Gel chromatography on G-75 Sephadexofsubcellularfractions from kidney cortexof rats in nonpretreated groups(Aand B)and CdCI2-pretreated groups(Cand D,0.5, 1, 1, 2,
and 2 mg Cd/kg as CdCI2 subcutaneously) 1hr(groups Aand C)and 4hr(groups Band D)after a challenge dose ofCdMT(0.4 mg Cd/kg as CdMT,sc). Column dimensions were26 x364
mm. Elution was carried out with 0.01 M Tris-HCI 0.05 M NaCI buffer, pH 7.5, containing 0.1% DOC and performed at 4°C. A portion of each fraction (3.5 ml) was assayed for
absorbance at250 nm(- ---)and radioactivityof109Cd( ).VeNo ofthe peaks No. 1,2, and 3 are0.80-1. 20, 1.20-1.40, and 1.60-2.10, respectively.
fraction at 4 hr in nonpretreated animals,
compared to only 49% ("membrane") and
28% ("microsome") in thepretreated animals.
Discussion
Employing the 109CdMT nephrotoxicity
model, the present studies demonstrated a
clear difference in 109Cd binding to mem-
brane proteins depending on whether or
not metallothionein synthesis had been
induced by pretreatment with nonradioac-
tive Cd. This difference in binding
occurred at 4 hr after injection ofthe toxic
agent (109CdMT). Experimental condi-
tions in the present study were identical
with those used previously (10) to demon-
strate that induction of metallothionein
synthesis by repeated injections of CdCl2
gives protection against the nephrotoxicity
normally encountered after an sc injection
ofCdMT at the dose O.,4 mg Cd/kg. It has
been assumed in these previous studies that
the increased intracellular concentrations of
metallothionein, induced by the pretreat-
ment, would constitute the biochemical
background for protection by sequestering
Cd2+ ions from interaction with sensitive
intracellular target sites. However, these
targets have not been identified and the
protective mechanism involving metalloth-
ionein hitherto has remained unproven.
The observations in the present study
provide new insights into these mecha-
nisms, both the one behind expression of
toxicity and the protective mechanism. The
findings are in agreement with a hypothesis
implying that sensitive targets of impor-
tance for development of Cd nephrotoxicity
are present in the HMW part ofthe mem-
brane and microsome fractions of renal
Table 2 Percentage of"'Cd recovered from G75 column bound in each protein peak in nonpretreated and pretreated
groups afterchallenge dose of CdMT.
Group A B C D
Peaknumber 1 3 1 3 1 3 1 2 3
Mitochondria 0.74 0.26 0.85 0.15 0.59 0.41 0.55 0.45
Lysosome 0.67 0.33 0.82 0.18 0.52 0.48 0.67 0.33
Membrane 0.50 0.50 0.88 0.12 0.53 0.47 0.49 0.21 0.30
Microsome 0.58 0.42 0.87 0.13 0.56 0.44 0.28 0.28 0.44
aNonpretreated, groupsAand B; treated, groups C and D. Testing 1 hrafterchallenge dose, groupsAand C; testing 4 hr
after challenge dose, groups B and D. Challenge dose of CdMT, 0.4 mg Cd/kg, administered subcutaneously. The ratio
values ofVe/Voforpeaks 1,2, and 3are0.80-1.20, 1.20-1.40, and 1.60-2.10, respectively.
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cortical cells and that the displacement of
Cd from these sites by competitive binding
to metallothionein (and possibly other low
molecular weight proteins) is responsible
for the protection ofthe pretreated animals
from development oftoxicity.
The timing of these observations, i.e.,
that the change in Cd binding to mem-
brane proteins is seen 4 hr after injection of
the toxic agent (CdMT) is in accordance
with previous observations (11,12) from
our laboratory demonstrating that
increased calciuria starts 4 to 8 hr after
CdMT injection. This early manifestation
of Cd nephrotoxicity occurs several hours
before tubular proteinuria appears. The
fact that the changed membrane binding of
Cd occurs simultaneously with the change
in the earliest indicator of tubular toxicity
(calciuria), gives further support to the idea
that there may be a causal link between Cd
binding to targets in the membrane frac-
tion and development oftoxicity.
It has been demonstrated that both
uptake and binding of Ca is impaired in
luminal as well as basolateral membranes of
renal tubule ofrats in the same experimen-
tal model (11) in which calciuria is also
seen. The Ca ion plays a central role in the
regulation of many vital cell functions
(16). It seems clear that a disruption of
intracellular Ca2+ homeostasis can poten-
tially lead to uncontrolled changes in such
functions, which may result in toxicity.
Cytosolic Ca2+ is normally maintained by
the connected operation of transport sys-
tems located in the plasma membrane,
endoplasmic reticulum, and mitochondria
(17). Cadmium is transported across cell
membranes by Ca2+ transports and Ca2+
channels. Furthermore, the presence ofCd
on these Ca2+ channel proteins, i.e., the
subcellular fraction proteins, affect Ca2+
movement at these sites (18). The data
presented support a hypothesis implying
the following events: wohen renal tubular
cells contain sufficient amounts ofmetallo-
thionein to bind a major proportion ofCd
released from the catabolized CdMT taken
up from tubular fluid, no toxicity occurs.
However, if insufficient metallothionein
protection is present, Cd interferes with
luminal and basolateral plasma membranes
and/or microsome function, with subse-
quent perturbations in Ca transport, lead-
ing to increased urinary Ca and increased
intracellular calcium.
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